Figure 2From: Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell lineGene transfer efficiency of the rAAV capsid mutant (EARVRPP; ) and a standard rAAV2-based vector (□) on primary human CML and CD34+ PBPC (in % GFP+ cells) using an MOI of 100. Data are given as mean ± SD (n ≥ 4).Back to article page